Read all the latest news articles from the Royal Society of Tropical Medicine and Hygiene
As part of a major new report, the Royal Society of Tropical Medicine and Hygiene (RSTMH) asked medical professionals from across the world what they think the next 25 years will hold for global health.
A future free of malaria, one of the world’s oldest and deadliest diseases, can be achieved as early as 2050, according to a new report published today by The Lancet Commission on malaria eradication.
International Health is fully open access from January 2020. This means that all previously published content will become free to view and all new content will have an associated article processing charge.
As an organisation, we are committed to establishing activities and programmes to better engage with our networks, including authors. This is why we feel it’s so important to ensure we hear the experiences and lessons learned directly from those delivering health programmes on the ground.
In partnership with ITN Productions Industry News, RSTMH has co-produced a news and current affairs-style programme “Access to Health: Global Challenges”.
Last week, the London School of Hygiene & Tropical Medicine launched their 14th virtual centre focusing on climate change and planetary health.
We are in the midst of the second largest Ebola outbreak in history – second only to the 2014 West African epidemic.
Today, Wellcome has announced an ambitious new £80 million programme to transform the way snakebite treatments are researched and delivered, to make them better, safer and more accessible for all.
This year we have seen a record number of applications for our small grants programme.
The government of Malawi has, this week, launched the world’s first malaria vaccine in a landmark pilot programme.
Ahead of World TB Day on 24 March, The Lancet Commission on Tuberculosis has published findings that estimate the savings from averting a TB death are three times the costs and may be much greater in many countries.
First evidence that repeated mass administration of ivermectin can reduce malaria incidence in children aged five or younger without an increase in adverse events for the wider population given the drug.
As we near International Volunteer Day on 5 December, I wanted to acknowledge the difficulties that so many of our volunteers have been facing due to the COVID-19 pandemic and celebrate their incredible efforts despite these challenges.
In 2020, we awarded 124 small grants to early career researchers, several of which focus on antimicrobial resistance. We asked three small grant awardees working in this space to talk about their research.
Antimicrobial Resistance (AMR), like almost everything else in the world over the last 10 months has been thrust into the shadows of COVID-19. Yet, it is still there, still increasing at an almost imperceptible rate.